Viewing nowCombinationOlduo Bijeong 5/20 mg
Olmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.

MFDS item code 201603902 · Approved 2016.06.24 · Insurance code 651205660
Treatment of essential hypertension not controlled by monotherapy
Amlodipine or Olmesartan Medoxomil is used for the treatment of essential hypertension. These medications help lower blood pressure when adequate control is not achieved alone. Managing hypertension reduces the risk of heart disease and stroke. Continuous use and treatment are important depending on the patient's condition. This enables stable blood pressure regulation.
Administer 1 tablet once daily with water, with or without food. It is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. Before administering this medicine, it is recommended that the dose of the individual components (amlodipine or olmesartan medoxomil) be adjusted. However, switching directly to this medicine may be considered if blood pressure is not controlled with monotherapy with the individual components. The maximum dose of this medicine is 10/40 milligrams. Since the maximum blood pressure-lowering effect occurs within 2 weeks after administration, adjust the dose at intervals of 2 weeks or more, taking the patient's blood pressure response into account. The recommended doses are as follows. - 5/20 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or olmesartan medoxomil 20 milligrams as monotherapy. - 10/20 milligrams: For patients whose blood pressure is not adequately controlled with olmesartan medoxomil 20 milligrams as monotherapy. - 5/40 milligrams: For patients whose blood pressure is not adequately controlled with 5/20 milligrams. - 10/40 milligrams: For patients whose blood pressure is not adequately controlled with 5/40 milligrams. ○ Patients with renal impairment: This medicine has not been studied in patients with renal impairment. However, in patients with mild to moderate renal impairment (creatine clearance 20-60mL/min), the maximum dose of olmesartan medoxomil is 20 milligrams once daily. This medicine is not recommended for patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or patients receiving dialysis. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. ○ Patients with reduced effective circulating blood volume: In patients who may have reduced effective circulating blood volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to start treatment at a low dose while closely monitoring their condition. ○ Patients with hepatic impairment: Use with caution in patients with mild to moderate hepatic impairment. The recommended initial dose of olmesartan medoxomil for patients with moderate hepatic impairment is 10 milligrams once daily, and the maximum dose is 20 milligrams once daily. In patients with hepatic impairment who are already receiving other antihypertensive medicines and/or diuretics, blood pressure and renal function should be monitored closely. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use, 2. Patients Who Must Not Receive This Medicine). ○ Elderly patients: In general, start treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and coexisting diseases. In elderly patients, blood pressure should be monitored closely and more frequently.
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age.
This medication can cause serious harm to the fetus and newborn when taken during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to any component of this medication, severely impaired liver function, nursing women, patients undergoing renal dialysis, and those with certain cardiac diseases should not take this medication. When this medication is used for the first time in patients with low fluid or sodium levels, blood pressure may drop too low, so their condition should be monitored closely. Due to its vasodilating effects, patients with severe aortic stenosis, obstructive coronary artery disease, or heart failure should exercise caution when taking this medication. Patients with reduced kidney function may experience worsening kidney function with this medication, so regular kidney function tests are necessary. Patients with impaired liver function should also exercise caution when taking this medication, and dosage adjustment may be necessary. Side effects such as dizziness, headache, hypotension, nausea, swelling, and others may occur during the use of this medication, so any unusual symptoms should be reported to healthcare providers. If blood pressure drops too low, the patient should rest lying down, and if necessary, receive IV fluids in a hospital. This medication may interact with other drugs, so it is essential to inform the doctor or pharmacist about any other medications being taken. Women who are pregnant or planning to become pregnant should choose other treatment options with proven safety instead of this medication, and they should stop taking it immediately if pregnancy is confirmed. Nursing mothers are advised to discontinue nursing or medication since this drug can transfer through breast milk. Children under 18 years of age should not use this medication due to lack of established safety and efficacy. Elderly patients should start with a lower dose considering the possibility of impaired liver and kidney function and should be closely monitored. In case of overdose, severe hypotension and cardiac function issues may occur due to vascular dilation, so immediate medical attention is required.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the drug’s efficacy and prevents deterioration.
White round film-coated tablet
Domestic - 28 tablets/PTP [14 tablets/PTP x 2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Samchundang Pharmaceutical Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg
Tablet · Prescription medication · Combination
Korea Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
Co., Ltd. Sainex
Olmesartan Medoxomil · Amlodipine Besylate
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.